Multi-asset

Ahead of OPEC meeting next week

Failed to build market share

Shifts in currency and equity positions

Seeded with £250m

Ensure consumer protection

Alternative finance becoming more mainstream

Concerns about US rate rise impact on EMs

Former BMO managers to run fund

Diversifying portfolios

Geoffrey C. Hsu, partner of OrbiMed and manager of the BiotechGrowth trust, assesses the key drivers for the sector in 2016 and beyond.